Pomalidomide-PEG4-azide

Background Introduction

Pomalidomide-PEG4-azide is a versatile PROTAC building block that combines the immunomodulatory drug pomalidomide—an E3 ligase ligand—with a PEG4 linker terminated by an azide functional group. This design enables rapid and efficient conjugation via click chemistry, making it a valuable tool for developing customized PROTAC molecules and molecular glues for targeted protein degradation.

Mechanism

The mechanism of Pomalidomide-PEG4-azide centers on its ability to recruit the cereblon (CRBN) E3 ubiquitin ligase complex through the pomalidomide moiety. When linked to a specific target protein ligand via the PEG4-azide handle, it forms a bifunctional molecule capable of simultaneously binding CRBN and the target protein. This proximity induces ubiquitination of the target protein, leading to its subsequent degradation by the proteasome. The azide group on the linker enables user-friendly click chemistry (e.g., CuAAC), simplifying the construction of diverse PROTAC molecules.

Applications

Pomalidomide-PEG4-azide is widely used in the synthesis of next-generation PROTACs and other heterobifunctional degraders. Its key applications include developing custom PROTACs for targeted protein degradation research, constructing protein degradation tools for drug discovery, and creating chemical probes to study protein function in cellular systems. The azide functionality also allows site-specific labelling, bioconjugation, and expansion into various click chemistry-based applications. This conjugate is highly valuable for oncology research, neurodegenerative disorder studies, and functional genomics screening.

• PEG4-azide functional group enables versatile click chemistry conjugation for streamlined PROTAC assembly.
• Pomalidomide moiety ensures high specificity and affinity for CRBN E3 ligase, supporting efficient protein degradation.

The E3 Ligase Ligand-Linker Conjugate Pomalidomide-PEG4-azide plays a crucial role in PROTACs by facilitating targeted protein degradation through its carefully designed structural components. It serves as a bridge between the E3 ligase and target protein, enhancing selectivity and efficiency. The following provides a detailed description of this molecule, focusing on the linker, ligand, and selection of target protein ligands.

Linker: The PEG4 linker in this molecule is characterized by its moderate length and flexible nature, allowing for optimal spatial arrangement between the ligand and the target protein. Its polyethylene glycol structure imparts water solubility and biocompatibility, while its non-cleavable nature ensures stability during the degradation process.

Ligand: The ligand component is Pomalidomide, a thalidomide derivative known for its high affinity to cereblon, an E3 ubiquitin ligase. Its structural characteristics allow efficient recruitment of the ligase complex, facilitating ubiquitination and subsequent degradation of the target protein.

Reactive Site: The azide group in this molecule serves as the reactive site, capable of forming covalent bonds with alkyne-functionalized target protein ligands through a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. This click chemistry approach ensures a robust and selective conjugation process.

Recommended Target Protein Ligand: A suitable warhead for this molecule is an alkyne-functionalized ligand, which offers precise conjugation via click chemistry. This compatibility provides a reliable method for attaching diverse protein targets, expanding the range of proteins that can be selectively degraded. Its application in experimental studies allows researchers to investigate protein function and therapeutic potential in cellular environments.